India · Delayed Price · Currency is INR Medistep Healthcare Statistics
Total Valuation
NSE:MEDISTEP has a market cap or net worth of INR 319.71 million. The enterprise value is 365.40 million.
| Market Cap | 319.71M |
| Enterprise Value | 365.40M |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:MEDISTEP has 14.21 million shares outstanding.
| Current Share Class | 14.21M |
| Shares Outstanding | 14.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 68.96% |
| Owned by Institutions (%) | n/a |
| Float | 3.74M |
Valuation Ratios
The trailing PE ratio is 4.81.
| PE Ratio | 4.81 |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 6.11 |
| EV / Sales | 0.52 |
| EV / EBITDA | 4.42 |
| EV / EBIT | 4.43 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.03, with a Debt / Equity ratio of 0.14.
| Current Ratio | 4.03 |
| Quick Ratio | 3.21 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.63 |
| Debt / FCF | -0.27 |
| Interest Coverage | 53.59 |
Financial Efficiency
Return on equity (ROE) is 21.69% and return on invested capital (ROIC) is 20.88%.
| Return on Equity (ROE) | 21.69% |
| Return on Assets (ROA) | 14.06% |
| Return on Invested Capital (ROIC) | 20.88% |
| Return on Capital Employed (ROCE) | 21.78% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 118.05M |
| Profits Per Employee | 9.97M |
| Employee Count | 6 |
| Asset Turnover | 1.93 |
| Inventory Turnover | 16.99 |
Taxes
In the past 12 months, NSE:MEDISTEP has paid 20.12 million in taxes.
| Income Tax | 20.12M |
| Effective Tax Rate | 25.17% |
Stock Price Statistics
The stock price has decreased by -34.69% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -34.69% |
| 50-Day Moving Average | 19.71 |
| 200-Day Moving Average | 23.90 |
| Relative Strength Index (RSI) | 63.32 |
| Average Volume (20 Days) | 13,950 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MEDISTEP had revenue of INR 708.31 million and earned 59.83 million in profits. Earnings per share was 4.68.
| Revenue | 708.31M |
| Gross Profit | 90.05M |
| Operating Income | 82.43M |
| Pretax Income | 79.95M |
| Net Income | 59.83M |
| EBITDA | 82.70M |
| EBIT | 82.43M |
| Earnings Per Share (EPS) | 4.68 |
Balance Sheet
The company has 6.13 million in cash and 51.81 million in debt, with a net cash position of -45.68 million or -3.21 per share.
| Cash & Cash Equivalents | 6.13M |
| Total Debt | 51.81M |
| Net Cash | -45.68M |
| Net Cash Per Share | -3.21 |
| Equity (Book Value) | 378.25M |
| Book Value Per Share | 26.62 |
| Working Capital | 377.12M |
Cash Flow
In the last 12 months, operating cash flow was -194.77 million and capital expenditures -91,000, giving a free cash flow of -194.86 million.
| Operating Cash Flow | -194.77M |
| Capital Expenditures | -91,000 |
| Depreciation & Amortization | 269,000 |
| Net Borrowing | 45.46M |
| Free Cash Flow | -194.86M |
| FCF Per Share | -13.71 |
Margins
Gross margin is 12.71%, with operating and profit margins of 11.64% and 8.45%.
| Gross Margin | 12.71% |
| Operating Margin | 11.64% |
| Pretax Margin | 11.29% |
| Profit Margin | 8.45% |
| EBITDA Margin | 11.68% |
| EBIT Margin | 11.64% |
| FCF Margin | n/a |
Dividends & Yields
NSE:MEDISTEP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 18.71% |
| FCF Yield | -60.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NSE:MEDISTEP has an Altman Z-Score of 5.03 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.03 |
| Piotroski F-Score | 4 |